Radiopharmaceuticals allow some types of cancer to be targeted with tailor-made therapies. The current state of the art was preceded by decades of intensive research – and the future promises even better treatment options.

Researchers at PSI are developing new technologies and drugs to eliminate tumours more effectively: with greater precision and personalised approaches

Researchers at PSI have established why the cells in our body react differently to stimuli and signals in old age compared with young cells. Their studies on human skin cells have shown that the chromatin, the packaged form of the DNA in the cell nucleus, plays a key role in this.